Turkkan J S, Hienz R D
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224.
Integr Physiol Behav Sci. 1992 Apr-Jun;27(2):142-50. doi: 10.1007/BF02698503.
Behavioral performances of normotensive and hypertensive adult male baboons were tested before, during, and following chronic oral dosing with verapamil. Performances during a five-color simultaneous match-to-sample task were measured for two doses (2.0, and 3.2 mg/kg/day) and vehicle. Each dose was administered for 21 consecutive days preceded and followed by 14-day baseline and recovery periods, respectively. Choice reaction times increased by 9% during the lower dose of verapamil, compared to vehicle; choice reaction times were unchanged at the higher dose. At baseline and during vehicle administration, the yellow and white stimuli were the most difficult to discriminate correctly; discrimination of these colors was slightly impaired by the lower, but not the higher dose of verapamil. Verapamil's behavioral effects were not modulated by blood pressure changes since both baboon groups showed equivalent changes in behavioral performance, but only renovascular hypertensive baboons showed blood pressure decreases. Verapamil appears to be an effective hypotensive and does not produce profound psychomotor impairment at clinically used doses during the first weeks of treatment.
在正常血压和高血压成年雄性狒狒长期口服维拉帕米之前、期间和之后,对其行为表现进行了测试。在一项五色同时样本匹配任务中,测量了两种剂量(2.0和3.2毫克/千克/天)的维拉帕米以及赋形剂的行为表现。每种剂量连续给药21天,给药前后分别有14天的基线期和恢复期。与赋形剂相比,较低剂量的维拉帕米给药期间选择反应时间增加了9%;较高剂量时选择反应时间未改变。在基线期和赋形剂给药期间,黄色和白色刺激最难正确辨别;较低剂量而非较高剂量的维拉帕米会轻微损害对这些颜色的辨别。维拉帕米的行为效应不受血压变化的调节,因为两组狒狒的行为表现变化相当,但只有肾血管性高血压狒狒的血压出现下降。维拉帕米似乎是一种有效的降压药,在治疗的最初几周内,临床使用剂量下不会产生严重的精神运动损害。